Abstract

This review provides a detailed analysis of the use of virtual library screening (VLS) in the drug discovery process. The first part is intended as a larger overview of the integrated VLS process. Small molecule and target macromolecule considerations will be described separately and will be subsequently integrated in a discussion of docking, scoring and evaluation. The second half of the review will focus on recent case studies that use VLS as part of an integrated drug discovery program. The case studies will illustrate the range of possible targets in VLS, provide an account of inclusive methodology and reveal the expectations for realistic goals. Recent efforts provide compelling evidence that VLS is successful when practiced in an integrated fashion involving synthetic, structural and computational expertise. Keywords: virtual screening, structure-based drug design, library design, drug discovery, diversity, filtering, ligand binding, docking

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.